MOULDER LEON O JR
SEC CIK 1228865 · EDGAR
BoughtSold
Most active insiders at ZLAB, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Du Ying | COB, CEO, Dir | — | $8.58M |
| 2 | Edmondson Frazor Titus III | CLO | — | $1.01M |
| 3 | Amado Rafael | See Remarks | — | $675.0K |
| 4 | Lis William | Dir | — | $340.0K |
| 5 | Smiley Joshua L | See Remarks | — | $294.3K |
| 6 | Chen Yajing | CFO | — | $239.3K |
| 7 | GAYNOR RICHARD | Dir | $65.8K | — |
| 8 | Leung Nisa | Dir | — | — |
| 9 | Vounatsos Michel | Dir | — | — |
| 10 | Morrison Scott W | Dir | — | — |
| 12 | MOULDER LEON O JR | Dir | — | — |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-22 16:08 | 2026-06-17 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Dir | A - Grant | $0.00 | +22.4K | 95.0K | +31% | $0 | |
| I | 2026-05-18 21:12 | 2026-05-18 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $16.88 | +60.0K | 96.9K | +162% | +$1.01M |
| MI | 2026-04-29 19:21 | 2026-04-28+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $17.79 | +60.0K | 1.79M | +3% | +$1.07M |
| MI | 2026-03-31 | 2026-03-30+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $18.91 | +54.0K | 1.73M | +3% | +$1.02M |
| 2026-02-03 | 2026-02-02 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $17.96 | +57.0K | 423.2K | +16% | +$1.02M | |
| M | 2026-01-09 | 2026-01-07+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $16.39 | +100.0K | 346.2K | +41% | +$1.64M |
| I | 2025-10-09 | 2025-10-07 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | See Remarks, Dir | P - Purchase | $20.85 | +36.9K | 36.9K | New | +$769.9K |
| 2025-06-23 | 2025-06-18 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Dir | A - Grant | $0.00 | +10.8K | 72.6K | +18% | $0 | |
| 2025-02-19 | 2025-02-18 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $6.67 | +25.0K | 266.2K | +10% | +$166.8K | |
| M | 2024-12-04 | 2024-12-03+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $10.26 | +70.0K | 196.2K | +55% | +$718.1K |
| M | 2024-11-20 | 2024-11-18+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $14.89 | +10.0K | 171.2K | +6% | +$148.9K |
| MI | 2024-09-20 | 2024-09-18+ | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | P - Purchase | $18.04 | +20.0K | 1.67M | +1% | +$360.8K |
| DMA | 2024-09-17 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | C - Cnv Deriv | — | +156.6K | 112.9K | New | — |
| DMAI | 2024-09-17 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | C - Cnv Deriv | — | +536.5K | 1.65M | +48% | — |
| DM | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | C - Cnv Deriv | — | +156.6K | 108.4K | New | — |
| DMI | 2024-09-16 | 2024-09-16 | ZBIO | Zenas BioPharma, Inc. | MOULDER LEON O JR | CEO, Dir | C - Cnv Deriv | — | +536.5K | 164.5K | New | — |
| 2024-06-20 | 2024-06-18 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Dir | A - Grant | $0.00 | +21.3K | 61.8K | +52% | $0 | |
| I | 2024-01-24 | 2024-01-22 | DNTH | Dianthus Therapeutics, Inc. /DE/ | MOULDER LEON O JR | Dir | A - Grant | $12.00 | +166.7K | 1.44M | +13% | +$2.00M |
| 2023-06-30 | 2023-06-29 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Dir | A - Grant | $26.45 | +18.9K | 40.5K | +87% | +$500.0K | |
| 2022-01-04 | 2022-01-03 | ZLAB | Zai Lab Ltd | MOULDER LEON O JR | Dir | A - Grant | $0.00 | +7,763 | 21.6K | +56% | $0 |
Purchase Sale Sale after option exercise All abbreviations